Akari Therapeutics (AKTX) Enterprise Value (2011 - 2026)
Akari Therapeutics' (AKTX) quarterly Enterprise Value came in at -$2.8 million in Q1 2026, down 4.77% year-on-year from -$2.9 million in Q1 2025, and up 46.8% quarter-over-quarter from -$5.2 million in Q4 2025.
Akari Therapeutics (AKTX) Enterprise Value (2011 - 2026) Analysis & Trends
Akari Therapeutics has disclosed Enterprise Value across 16 years of filings, most recently posting -$2.8 million for Q1 2026.
- Enterprise Value for Q1 2026 came in at -$2.8 million, down 4.77% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.8 million (down 4.77% YoY), and the FY2025 annual result was -$5.2 million, down 95.68% from the prior year.
- Enterprise Value came in at -$2.8 million for Q1 2026 at Akari Therapeutics, up from -$5.2 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$162567.0 in Q3 2025 to a low of -$13.2 million in Q4 2022.
- The 5-year median for Enterprise Value is -$2.7 million (2025), against an average of -$3.7 million.
- Peak annual rise in Enterprise Value reached 92.76% in 2025, while the deepest fall reached 101.68% in 2025.
- Akari Therapeutics' Enterprise Value stood at -$13.2 million in 2022, then surged by 70.98% to -$3.8 million in 2023, then surged by 30.85% to -$2.7 million in 2024, then sank by 95.68% to -$5.2 million in 2025, then soared by 46.8% to -$2.8 million in 2026.
- The last three Enterprise Value figures came in at -$2.8 million (Q1 2026), -$5.2 million (Q4 2025), and -$162567.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -584.73 Mn |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | -8.75 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.77 Mn |
| Dec 31, 2025 | -5.20 Mn |
| Sep 30, 2025 | -162,567.00 |
| Jun 30, 2025 | -2.71 Mn |
| Mar 31, 2025 | -2.64 Mn |
| Dec 31, 2024 | -2.66 Mn |
| Sep 30, 2024 | -2.25 Mn |
| Jun 30, 2024 | -4.18 Mn |
| Mar 31, 2024 | -1.31 Mn |
| Dec 31, 2023 | -3.85 Mn |
| Dec 31, 2022 | -13.25 Mn |
| Dec 31, 2021 | -9.36 Mn |
| Sep 30, 2020 | -12.32 Mn |
| Jun 30, 2020 | -12.75 Mn |
| Mar 31, 2020 | -7.82 Mn |
| Dec 31, 2019 | -5.73 Mn |
| Sep 30, 2019 | -6.27 Mn |
| Jun 30, 2019 | -2.74 Mn |
| Mar 31, 2019 | -6.15 Mn |
| Dec 31, 2018 | -5.45 Mn |